Skip to main content
Equibles

LEGN · Legend Biotech Corp

Track LEGN — free

Use LEGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.52 -0.23 (-1.06%) At close · Sep 4
Rebalance outlook locked
Market Cap
$4.19B
Shares
194.49M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$21.52 Open$21.52 Day$21.41–21.90 52W close$16.65–36.28 Avg vol 30d2.4M Short int17.8M · 9.2% float · 7.2d Short vol47% Last earningsAug 11, 2026 DataJun 2020–Sep 2026

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 9 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-38.5%
Trailing year
Short interest
9.2%
Latest settlement · 7.2 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross Death cross
Price vs 200-day avg −7%
below
Price vs 50-day avg −5%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 25%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +4%
trailing
6-month return +13%
trailing
YTD return −1%
this year
Relative strength −2%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Death cross
50d $23 › 200d $23 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +56 funds added
Insider flow Distributing
Net -$171.1K over 90 days · 100% sells
Short interest Falling
9.16% of float · ▼ -1.6% MoM · 7.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
221 holders — near 3-yr high, broad support
Squeeze score 58
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 74%
annualized · 1-yr
Max drawdown −54%
past year
ATR 4.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
Death cross Bearish
Price vs 200-day avg
−7% Bearish
Price vs 50-day avg
−5% Bearish
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
25% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) Death cross
50d $23 › 200d $23 — 200d above 50d
Institutional flow Accumulating
+14% holders QoQ · +56 funds added
Insider flow Distributing
Net -$171.1K over 90 days · 100% sells
Short interest Falling
9.16% of float · ▼ -1.6% MoM · 7.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
221 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $17 Now $22 · 25% Range high $36
vs 200-day avg -7% vs 50-day avg -5% 50-day below 200-day death cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LEGN
Legend Biotech Corp
this stock
$4.19B -1.0% — — 9.2%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $138.42B +20.5% +46.2% 31.8 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $85.22B +7.2% +20.8% 20.5 2.3%
ARGX
Argenx SE
 $64.25B +22.9% — — 1.9%
CSLLY
Csl Ltd
 $60.55B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
221
% held
53.5%
Net QoQ
+6.9M sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
157
View
Short & Settlement
Short Interest Falling
Shares short
17.8M
Days to cover
7.2d
Change
-289.8K sh
View
Short Volume
Short vol %
47%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
947
Value
$19.2K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
52.7%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$171.1K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 18, 2026
This year
19
View
Proposed Sales
Value
$88.8K
Shares
3.0K
Filed
Jun 30, 2026
View
Exempt Offerings
Offering
$200.0M
Filed
Apr 28, 2023
View
Earnings & Events
Earnings Calls Upcoming
Next call
Sep 15, 2026
Last call
Aug 11, 2026
View
Investor Relations
Latest news
Legend Biotech to Participate in…
Published
Sep 1, 2026
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
LEGN +8.3% +3.7% +12.7% +3.6% -1.0%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +8.1% +4.1% -2.5% +3.2% -14.0%
Key facts CIK 1801198 CUSIP 52490G102 13F (30d) 142 filings 142 filers Visit website Investor relations